← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2005Last known activity
Jun 28, 2017
Acquired by Histogen on Jan 29, 2020
Timeline
2000s
- Jul 1, 2005
Conatus Pharmaceuticals— Founded
2010s
- Aug 2, 2010
Idun Pharmaceuticals— Acquired
2020s
- Jan 29, 2020
Histogen— Acquired By
Drugs by trial phase (4 distinct, 20 trials)
Phase 2 (3 own, 1 via acquisition)
Indications
Studied for
- Carcinoma, Hepatocellular
- Cholestasis
- Digestive System Diseases
- Fatty Liver
- Fibrosis
- Gastrointestinal Diseases
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis C
- Hepatitis C, Chronic
- Hypertension
- Hypertension, Portal
- Kidney Diseases
- Liver Cirrhosis
- Liver Diseases
- Liver Failure
- Liver Failure, Acute
- Non-alcoholic Fatty Liver Disease
- Renal Insufficiency
- Virus Diseases
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (34)
- NCT03205345Lead sponsorPhase 2Jun 28, 2017
- NCT03462576CollaboratorN/AJun 28, 2017
- NCT03205345Study directorPhase 2Jun 28, 2017
- NCT02960204Study chairPhase 2Oct 17, 2016
- NCT02960204Lead sponsorPhase 2Oct 17, 2016
- NCT03439189CollaboratorN/AAug 28, 2016
- NCT02686762Lead sponsorPhase 2Jan 1, 2016
- NCT02686762Study chairPhase 2Jan 1, 2016
- NCT02230683Study chairPhase 2Aug 1, 2014
- NCT02230670Study chairPhase 2Aug 1, 2014
- NCT02230683Lead sponsorPhase 2Aug 1, 2014
- NCT02230670Lead sponsorPhase 2Aug 1, 2014
- NCT02138253Lead sponsorPhase 2May 1, 2014
- NCT02138253Study chairPhase 2May 1, 2014
- NCT02121860Study chairPhase 1Apr 1, 2014
Details
- Founded
- San Diego, CA, US Jul 1, 2005
- Last known activity
- Jun 28, 2017